Comments to DEA: Exemption of Sales by Retail Distributors of Pseudoephedrine and Phenylpropanolamine Products

Docket Number:

DEA-239T

These comments are in response to the "interpretive rule" DEA published to provide a "Clarification of the Exemption of Sales by Retail Distributors of Pseudoephedrine and Phenylpropanolamine Products."

Download Document

Issues:

OTC Medicines

PSE (Pseudoephedrine)

Comments to DEA: Exemption of Sales by Retail Distributors of Pseudoephedrine and Phenylpropanolamine Products

Related Posts